Login to Your Account



Earnings Roundup

Enbrel Drives Amgen Earnings; Company Shoots High for Year

By Randy Osborne
Staff Writer

Friday, January 25, 2013
Detailing mixed fourth-quarter financial results, Amgen Inc.'s officials adopted a look-ahead approach in the earnings conference call, putting forth optimistic guidance for 2013 and pledging more detail on pipeline strategies during the business review slated for early next month.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription